John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 19,045 shares at $30.20 ($563K) on 2015-03-30, disclosed to the SEC on 2015-04-01.
Scheduled sale ($563k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.20 | 14,500 | $438K | 77.8% |
| 2 | $27.42 | 4,545 | $125K | 22.2% |
| Total | $29.54 avg | 19,045 | $563K | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |